Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trade groups on steroids

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry again urges athletes who claim that contaminated supplements caused them to fail steroid tests name the products they used, according to a joint release by the American Herbal Products Association, National Nutritional Foods Association and Utah Natural Products Alliance. The statement was made in light of Major League Baseball's recent announcement of tougher policies on steroid usage. The groups also are "asking FDA to act promptly to investigate any identified product and move forward as appropriate." The call for players to step forward about their product use was first issued by the groups in September (1"The Tan Sheet" Sept. 26, 2005, p. 10). Contaminated products "are illegal drugs that are masquerading as legitimate supplements in the face of inadequate enforcement," the current release states. "Broad allegations against the entire class of products are inaccurate and cannot be tolerated"...

You may also be interested in...



Players Blaming Supplements Need To Name Names – Trade Groups

Industry trade groups are urging athletes to release the names of any allegedly contaminated supplements they hold responsible for positive steroid test results

EU ‘Structured Dialog’ Offers Opportunity To Secure Supply

A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.

Adcock Struggles As South African Healthcare Awaits Relief

Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel